Advertisement
ICCM vs PEN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCM is a Hold and PEN is a Hold.
ICCM's Indicator enters downward trend
The Aroon Indicator for ICCM entered a downward trend on November 02, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 227 similar instances where the Aroon Indicator formed such a pattern. In 201 of the 227 cases the stock moved lower. This puts the odds of a downward move at 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for ICCM just turned positive on October 19, 2026. Looking at past instances where ICCM's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.
Following a +3.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICCM advanced for three days, in 160 of 206 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
ICCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.304) is normal, around the industry mean (4.204). P/E Ratio (-0.115) is within average values for comparable stocks, (1.723). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (1.297) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. ICCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
PEN in downward trend: price expected to drop as it breaks its higher Bollinger Band on October 20, 2026
PEN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 38 similar instances where the stock broke above the upper band. In 29 of the 38 cases the stock fell afterwards. This puts the odds of success at 76%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for PEN moved out of overbought territory on October 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 23 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 55 cases where PEN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 64%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PEN as a result. In 55 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for PEN turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 25 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
The Aroon Indicator for PEN entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
PEN moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PEN crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +1.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in 197 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. PEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.269) is normal, around the industry mean (4.204). P/E Ratio (78.376) is within average values for comparable stocks, (1.723). Projected Growth (PEG Ratio) (3.597) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (8.354) is also within normal values, averaging (40.124).
ICCM | PEN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 2 | 87 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 42 Fair valued | 94 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 76 | |
SMR RATING 1..100 | 100 | 66 | |
PRICE GROWTH RATING 1..100 | 96 | 47 | |
P/E GROWTH RATING 1..100 | 7 | 18 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ICCM's Valuation (42) in the null industry is somewhat better than the same rating for PEN (94) in the Medical Specialties industry. This means that ICCM’s stock grew somewhat faster than PEN’s over the last 12 months.
PEN's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as ICCM (100) in the null industry. This means that PEN’s stock grew similarly to ICCM’s over the last 12 months.
PEN's SMR Rating (66) in the Medical Specialties industry is somewhat better than the same rating for ICCM (100) in the null industry. This means that PEN’s stock grew somewhat faster than ICCM’s over the last 12 months.
PEN's Price Growth Rating (47) in the Medical Specialties industry is somewhat better than the same rating for ICCM (96) in the null industry. This means that PEN’s stock grew somewhat faster than ICCM’s over the last 12 months.
ICCM's P/E Growth Rating (7) in the null industry is in the same range as PEN (18) in the Medical Specialties industry. This means that ICCM’s stock grew similarly to PEN’s over the last 12 months.
| ICCM | PEN | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 59% |
| Stochastic ODDS (%) | 2 days ago 88% | 2 days ago 64% |
| Momentum ODDS (%) | N/A | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 57% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 71% |
| Advances ODDS (%) | 9 days ago 78% | 15 days ago 65% |
| Declines ODDS (%) | 2 days ago 88% | 7 days ago 63% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 62% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ICCM’s FA Score shows that 1 FA rating(s) are green while PEN’s FA Score has 1 green FA rating(s).
- ICCM’s FA Score: 1 green, 4 red.
- PEN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ICCM’s TA Score shows that 4 TA indicator(s) are bullish while PEN’s TA Score has 3 bullish TA indicator(s).
- ICCM’s TA Score: 4 bullish, 2 bearish.
- PEN’s TA Score: 3 bullish, 7 bearish.
Price Growth
ICCM (@Medical/Nursing Services) experienced а -24.39% price change this week, while PEN (@Medical/Nursing Services) price change was -1.19% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.01%. For the same industry, the average monthly price growth was -7.51%, and the average quarterly price growth was -8.84%.
Reported Earning Dates
ICCM is expected to report earnings on Nov 18, 2026.
PEN is expected to report earnings on Feb 23, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.01% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ICCM and
Correlation & Price change
A.I.dvisor indicates that over the last year, ICCM has been closely correlated with SINT. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICCM jumps, then SINT could also see price increases.
| Ticker / NAME | Correlation To ICCM | 1D Price Change % | ||
|---|---|---|---|---|
| ICCM | 100% | -9.08% | ||
| SINT - ICCM | 67% Closely correlated | -1.71% | ||
| ILMN - ICCM | 31% Poorly correlated | +5.13% | ||
| PEN - ICCM | 31% Poorly correlated | -0.41% | ||
| BRKR - ICCM | 29% Poorly correlated | +1.45% | ||
| BNGO - ICCM | 29% Poorly correlated | +3.45% | ||
More | ||||
PEN and
Correlation & Price change
A.I.dvisor indicates that over the last year, PEN has been loosely correlated with ISRG. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To PEN | 1D Price Change % | ||
|---|---|---|---|---|
| PEN | 100% | -0.41% | ||
| ISRG - PEN | 42% Loosely correlated | +0.89% | ||
| HAE - PEN | 41% Loosely correlated | +0.12% | ||
| MMSI - PEN | 35% Loosely correlated | -0.18% | ||
| SMTI - PEN | 34% Loosely correlated | +0.31% | ||
| ATRC - PEN | 33% Loosely correlated | +0.89% | ||
More | ||||